What it sells
AI plus rapid-experiment platform (Orchard) to discover gene-editing targets and design plant traits for crops.
Business model breakdown
Buyer: who owns the budget?
UnverifiedR&D and trait-discovery heads at seed, crop-science and plant-breeding companies (partnership with BASF announced); inferred.
Trigger: what makes them buy now?
Breeding for yield can erode nutrition and flavour; partners want novel, non-canonical targets and faster hypothesis testing than conventional discovery.
Workflow: what inputs become what output?
Foundational multimodal modelling, agentic prioritisation, rapid in vitro/transient testing, then trait validation in commercial plant systems.
Economics: what it saves and how it charges
Partnership model in three depths: computational discovery, complex edit design, end-to-end trait creation; customer owns downstream trait IP for prediction-only programmes.
Distribution: how it reaches customers
Partnership/enquiry-led ("Talk to us about a crop, trait or biological challenge").
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-01-07 | — | €8M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.